These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma. Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589 [TBL] [Abstract][Full Text] [Related]
4. Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response. Ahmed A; Halama N Anticancer Res; 2020 Nov; 40(11):6367-6373. PubMed ID: 33109574 [TBL] [Abstract][Full Text] [Related]
5. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609 [TBL] [Abstract][Full Text] [Related]
6. Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer. Kroeger DR; Milne K; Nelson BH Clin Cancer Res; 2016 Jun; 22(12):3005-15. PubMed ID: 26763251 [TBL] [Abstract][Full Text] [Related]
7. Sustained innate interferon is an essential inducer of tertiary lymphoid structures. Calvanese AL; Cecconi V; Stäheli S; Schnepf D; Nater M; Pereira P; Gschwend J; Heikenwälder M; Schneider C; Ludewig B; Silina K; van den Broek M Eur J Immunol; 2024 Oct; 54(10):e2451207. PubMed ID: 38980268 [TBL] [Abstract][Full Text] [Related]
8. Human NKp44 Ikeda A; Ogino T; Kayama H; Okuzaki D; Nishimura J; Fujino S; Miyoshi N; Takahashi H; Uemura M; Matsuda C; Yamamoto H; Takeda K; Mizushima T; Mori M; Doki Y Cancer Immunol Res; 2020 Jun; 8(6):724-731. PubMed ID: 32229590 [TBL] [Abstract][Full Text] [Related]
9. Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular-cholangiocarcinoma. Gong W; Zhang S; Tian X; Chen W; He Y; Chen L; Ding T; Ren P; Shi L; Wu Q; Sun Y; Chen L; Guo H Hepatol Int; 2024 Aug; 18(4):1310-1325. PubMed ID: 38767772 [TBL] [Abstract][Full Text] [Related]
10. A high-resolution view of intra-tumoral B cell immunity. Hu X; Liu XS Immunity; 2022 Mar; 55(3):387-389. PubMed ID: 35263565 [TBL] [Abstract][Full Text] [Related]
16. Tertiary lymphoid structures in the era of cancer immunotherapy. Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904 [TBL] [Abstract][Full Text] [Related]
17. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma. Liu Z; Meng X; Tang X; Zou W; He Y Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914 [TBL] [Abstract][Full Text] [Related]
18. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer. Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J Front Immunol; 2022; 13():962056. PubMed ID: 36189233 [TBL] [Abstract][Full Text] [Related]
19. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice. Delvecchio FR; Fincham REA; Spear S; Clear A; Roy-Luzarraga M; Balkwill FR; Gribben JG; Bombardieri M; Hodivala-Dilke K; Capasso M; Kocher HM Cell Mol Gastroenterol Hepatol; 2021; 12(5):1543-1565. PubMed ID: 34252585 [TBL] [Abstract][Full Text] [Related]
20. Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma. Xiong G; Shan J; Chong Q; Cui Y Aging (Albany NY); 2024 Apr; 16(8):6898-6920. PubMed ID: 38709170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]